Vera Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q1 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Vera Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q1 2022 to Q3 2025.
  • Vera Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending September 30, 2025 was $995K.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)

Vera Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $995K Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $995K +$995K Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $995K +$995K Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $966K +$966K Dec 31, 2024 10-K 2025-02-28
Q2 2024 $0 $0 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $0 $0 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $0 -$1.88M -100% Dec 31, 2023 10-K 2024-03-27
Q3 2023 $0 -$1.88M -100% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $0 -$1.88M -100% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $0 -$1.88M -100% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.88M Dec 31, 2022 10-K 2023-03-28
Q3 2022 $1.88M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.88M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.88M Mar 31, 2022 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.